Teva Pharmaceutical Industries (TEVA) Other Non-Current Assets: 2009-2025
Historic Other Non-Current Assets for Teva Pharmaceutical Industries (TEVA) over the last 12 years, with Sep 2025 value amounting to $1.8 billion.
- Teva Pharmaceutical Industries' Other Non-Current Assets rose 294.12% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 294.12%. This contributed to the annual value of $1.8 billion for FY2024, which is 276.81% up from last year.
- As of Q3 2025, Teva Pharmaceutical Industries' Other Non-Current Assets stood at $1.8 billion, which was down 1.79% from $1.8 billion recorded in Q2 2025.
- Teva Pharmaceutical Industries' 5-year Other Non-Current Assets high stood at $1.8 billion for Q2 2025, and its period low was $434.0 million during Q2 2024.
- In the last 3 years, Teva Pharmaceutical Industries' Other Non-Current Assets had a median value of $470.0 million in 2024 and averaged $949.0 million.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Other Non-Current Assets tumbled by 36.98% in 2021 and then surged by 324.42% in 2025.
- Quarterly analysis of 5 years shows Teva Pharmaceutical Industries' Other Non-Current Assets stood at $515.0 million in 2021, then decreased by 14.37% to $441.0 million in 2022, then rose by 6.58% to $470.0 million in 2023, then soared by 276.81% to $1.8 billion in 2024, then soared by 294.12% to $1.8 billion in 2025.
- Its Other Non-Current Assets stands at $1.8 billion for Q3 2025, versus $1.8 billion for Q2 2025 and $1.8 billion for Q1 2025.